Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhenzhilun (sodium hyaluronate eye drops) plus hot compress FS-01 for dry eye
ChiCTR2300076569Phase 4Recruiting
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium hyaluronate in dry eye syndrome (DED), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoints: Chinese dry eye questionnaire scale and Visual fatigue test and evaluation scale. Started Apr 2023; status: recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2300076569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076569.